Caffeine consumption and risk of dyskinesia in CALM-PD-Reference-Cited by-同舟云学术

Caffeine consumption and risk of dyskinesia in CALM-PD

Published:2013-01-21 Issue:3 Volume:28 Page:380-383
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Wills Anne-Marie A.¹,Eberly Shirley²,Tennis Marsha¹,Lang Anthony E.³,Messing Susan²,Togasaki Daniel⁴,Tanner Caroline M.⁵,Kamp Cornelia⁶,Chen Jiang-Fan⁷,Oakes David²,McDermott Michael P.²⁶,Schwarzschild Michael A.¹,

Affiliation:

1. Department of Neurology; Massachusetts General Hospital; Boston Massachusetts USA

2. Department of Biostatistics and Computational Biology; University of Rochester; Rochester New York USA

3. Department of Medicine; Division of Neurology; University of Toronto; Edmond J. Safra Program in Parkinson's Disease University Health Network; Toronto Ontario Canada

4. Department of Neurology; University of Southern California; Los Angeles Los Angeles California USA

5. Parkinson's Institute; Sunnyvale California USA

6. Department of Neurology; Center for Human Experimental Therapeutics; University of Rochester; Rochester New York USA

7. Molecular Neuropharmacology Laboratory; Boston University; Boston Massachusetts USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.25319/fullpdf

Reference21 articles.

1. A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease;Bibbiani;Exp Neurol.,2003